SCHEMBL2637575

SCHEMBL2637575

Cc1c(C(F)(F)F)[nH]c2c(NC(=O)c3ccccc3F)c(=O)[nH]n2c1=O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 5/20 0.38
LMNA P02545 3/20 0.38
HTT P42858 2/20 0.38
TRPV1 Q8NER1 1/20 0.37
CNR2 P34972 1/20 0.37
NPC1 O15118 3/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 2/20 0.37
RAB9A P51151 2/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637588 0.87 KMT2A (0.45) MAPTKMT2AMEN1SMN1; SMN2LMNA
SCHEMBL3409988 0.78 MAPT (0.53) MAPTKMT2AMEN1TDP1SMN1; SMN2
SCHEMBL3413627 0.75 MAPT (0.46) MAPTKMT2AMEN1TDP1SMN1; SMN2
SCHEMBL2637547 0.72 NPC1 (0.48) MAPTKMT2AMEN1TDP1SMN1; SMN2
SCHEMBL2637595 0.69 MAPT (0.43) MAPTKMT2AMEN1TDP1SMN1; SMN2
SCHEMBL2637406 0.69 MAPT (0.41) MAPTKMT2AMEN1TDP1SMN1; SMN2
SCHEMBL2638375 0.68 MAPT (0.48) MAPTKMT2AMEN1TDP1SMN1; SMN2
SCHEMBL27785087 0.65 MEN1 (0.50) MAPTKMT2AMEN1TDP1SMN1; SMN2
SCHEMBL15410721 0.64 MEN1 (0.56) MAPTKMT2AMEN1TDP1SMN1; SMN2
SCHEMBL3409206 0.63 MAPT (0.47) MAPTKMT2AMEN1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed